Immediate Impact

65 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
5 intermediate papers

Works of Ran Liao being referenced

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
2022
FRI0164 INCIDENCE RATE AND CHARACTERIZATION OF HERPES ZOSTER IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: AN UPDATE FROM BARICITINIB CLINICAL STUDIES
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Ran Liao 43 60 9 54 49 27 283
Mohammad Amin Kashef 30 13 2 53 14 26 267
Pearl Pai 27 76 22 50 34 287
Pampa Ch Toi 39 56 1 38 14 37 259
Sylvia Aidé Martínez‐Cabriales 8 62 52 85 26 258
Yuichi Matsuno 63 26 52 11 24 275
Juan S. Lasa 26 85 118 37 19 330
Wendy Komocsar 27 102 4 45 7 28 328
Ahmed Mourad 24 45 64 129 27 280
Christopher McMaster 19 104 2 12 22 17 241
Ruxandra Ionescu 36 133 2 24 16 34 293

All Works

Loading papers...

Rankless by CCL
2026